Vestal Point Capital’s Terns Pharmaceuticals TERN Stock Holding History

Vestal Point Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000,000	Closed	-$52.7M	–	91
2026 Q1	$52.7M	Sell	1,000,000 -3,500,000	-78%	-$144M	1.47%	23
2025 Q4	$182M	Buy	+4,500,000	New	+$104M	6.18%	4

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vestal Point Capital's TERN Position: Q2 2026 in Review

Vestal Point Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,000,000 shares — an estimated $52.7M sold.

Vestal Point Capital first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $182M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Vestal Point Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Vestal Point Capital sold 1,000,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $52.7M.
Vestal Point Capital first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Vestal Point Capital's Terns Pharmaceuticals position peaked at $182M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.